research COVID-19 pandemic and teledermatology in low-income regions
The COVID-19 pandemic increased the use of teledermatology to treat skin conditions in low-income areas, despite challenges like poor photo quality.
Search
for
Sort by
Research
210-240 / 1000+ results 
research Increased risk of chronic fatigue and hair loss following COVID-19 in individuals with hypohidrotic ectodermal dysplasia
People with hypohidrotic ectodermal dysplasia are more likely to experience long-term fatigue and hair loss after COVID-19.
research A comment on psychological distress and women’s hair loss related to the COVID-19 pandemic
The COVID-19 pandemic has increased hair loss and psychological distress in women.
research COVID‐19 dermatological manifestations: results from the Mexican Academy of Dermatology COVID‐19 registry
COVID-19 can cause skin issues like hives, rashes, and chickenpox-like eruptions, with women aged 31-40 being the most affected.
research A response to “Male balding is a major risk factor for severe COVID-19”
The authors suggest that scalp hair might protect against COVID-19 and call for more research on scalp health and the virus.
research Reply to: “Comment on ‘Androgenetic alopecia present in the majority of patients hospitalized with COVID-19’”
High incidence of hair loss found in COVID-19 patients, but no severity correlation established.
research Examining the long‐term effects of COVID‐19 in surgical nurses: Case of Aegean Region
COVID-19 has caused lasting physical and mental health issues for surgical nurses.
research Clinical Manifestation of Alopecia Areata After COVID-19 Infection or Vaccination
COVID-19 may trigger alopecia areata, but more research is needed.
research Cutaneous manifestations associated with COVID-19 infection at a university hospital in eastern China
Skin symptoms like rashes and sores can indicate COVID-19 severity, especially in older people.
research Undesirable effects of COVID-19 vaccination on Saudi population: A descriptive study, Winter 2022.
COVID-19 vaccines caused some side effects in the Saudi population.
research Post-COVID Telogen Effluvium.
COVID-19 may cause temporary hair loss, which usually gets better on its own, but reducing stress and managing health issues might help recovery.
research Cutaneous Manifestations in Patients With COVID-19 Treated at a University Hospital in Southern Brazil
Some COVID-19 patients have skin issues, with men, ICU patients, and those on multiple antibiotics at higher death risk; in-person skin checks by dermatologists are more effective.
research The Association Between Hair Loss and COVID-19: The Impact of Hair Loss After COVID-19 Infection on the Quality of Life Among Residents in Saudi Arabia
Over half of the participants in a Saudi Arabian survey experienced hair loss after COVID-19, affecting women and younger people more, with a small percentage feeling a severe impact on their lives.
research PO.8.170 Drug-induced lupus or systemic lupus erythematosus after experimental COVID-19 therapy: difficulties in differential diagnosis
Distinguishing drug-induced lupus from systemic lupus is challenging and requires careful monitoring.
research COVİD-19’UN GÜNCEL BELİRTİLERİNİN LİTERATÜR DERLEMESİ
Covid-19 can cause skin and oral symptoms, like taste changes, which help in detection and management.
research Therapy experience in alopecia after COVID-19
The treatment with an oral drug and topical lotion is effective and well-tolerated for hair loss after COVID-19.
research Rational evaluation of patients with COVID-19-related hair loss
COVID-19 can cause different types of hair loss, and proper diagnosis by a specialist may be needed.
research Global Impact of Coronavirus Disease 2019 (COVID-19)
COVID-19 has widely affected health, various industries, and the economy, but also led to more remote work and less pollution.
research Platelet‐Rich Plasma Treatment for Accelerated Androgenetic Alopecia Pattern Hair Loss After COVID‐19 Infection: A Case Series
PRP treatment effectively reduces hair loss after COVID-19.
research Impact of Covid-19 on asthmatic patients in Western region in Saudi Arabia
Covid-19 affected asthmatic patients in Western Saudi Arabia.
research Gestational diabetes mellitus and COVID-19, clinical characteristics and review of the literature
Pregnant women with COVID-19 and gestational diabetes may face severe complications, and more research is needed on their outcomes.
research Increase in Google Trends Regarding Telogen Effluvium Due To COVID-19
Public interest in hair loss increased during the COVID-19 pandemic.
research NOVEL CORONAVIRUS (SARS-COV-2): MOLECULAR BIOLOGY, PATHOGENESIS, PATHOBIOLOGY AND ADVANCES IN TREATMENT OF COVID-19 PATIENTS– AN UPDATE
COVID-19 is caused by a virus from bats, and efforts focus on prevention and treatment research.
research Reply to letter to the editor: “A response to ‘Male balding is a major risk factor for severe COVID-19’”
Balding might help identify men at higher risk for severe COVID-19, but more research is needed.
research COVID-19感染症でみられる皮膚病変
COVID-19 can cause various skin symptoms, with different patterns seen in younger and older patients.
research Hormone replacement therapy and COVID-19 outcomes in solid organ transplant recipients compared with the general population
Hormone replacement therapy may lower the risk of severe COVID-19 outcomes in non-immunosuppressed people and male organ transplant recipients.
research Telogen Effluvium and COVID-19: a case and a brief review of literature
COVID-19 may cause temporary hair loss due to the body's immune response.
research Eflúvio telógeno como sintoma da “Covid longa” em pacientes pré-infectados por SARS-CoV-2: uma revisão integrativa de literatura
Hair loss is a symptom of long COVID and can be treated with a protein-rich diet.
research A Case of Telogen Effluvium as COVID Sequelae
A woman lost over 80% of her hair due to a condition called telogen effluvium after having COVID-19.
research Reporting Cases of Telogen Effluvium as a sequelae of COVID‐19 Infection
COVID-19 can cause temporary hair loss, known as Telogen Effluvium, within two months of infection.